Newbridge Financial Services Group, Inc. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 39 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,0000.0%1,2690.0%0.00%
+100.0%
Q1 2022$3,000
-50.0%
1,269
-16.0%
0.00%
-66.7%
Q4 2021$6,0000.0%1,5100.0%0.00%
-25.0%
Q3 2021$6,000
+200.0%
1,510
+194.3%
0.00%
+300.0%
Q2 2021$2,000
-60.0%
5130.0%0.00%
-75.0%
Q1 2021$5,000
+25.0%
513
+20.1%
0.00%
+33.3%
Q4 2020$4,000
+100.0%
4270.0%0.00%
+50.0%
Q3 2020$2,0004270.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders